“É possível fazer os médicos portugueses prescreverem mais genéricos”

18 July 2017

Jacek Glinka: “Biossimilares podem poupar ao SNS 120 milhões de euros”

18 July 2017

Pharma expert: EU drug agency should be ‘easily’ accessible to all

18 July 2017

Biosimilars at work: Access. Experience. Science.

1 April 2017

Biosimilar medicines are a part of today’s therapeutic armamentarium – […]

Access to Medicines at Sustainable Price: Pharma Industry and Governments Transforming Challenges into Opportunities

23 March 2017

Biosimilar interchangeability: Do you know your switching from your substitution?

21 March 2017

US FDA interchangeability guidance adds another level of confusion over […]

Some EU countries effectively delay market entry of generics

17 March 2017

The harmonisation of different regulatory environments in the EU member […]

Biosimilar medicines: Increasing access to modern essential medicines while supporting sustainability of healthcare systems

16 February 2017

Biologic medicines have revolutionised the management of many serious diseases […]

Biosimilar medicines. Essential for increasing access to important medicines and the sustainability of healthcare systems

25 January 2017

Biologic medicines have revolutionised the management of many serious diseases […]

The global scourge of counterfeit medicines

8 November 2016

The statistics are truly disturbing, with an annual death toll […]